Takeda Pharmaceutical’s experimental narcolepsy drug has significantly improved outcome for patients in late-stage clinical trials, and could become the first treatment to target the disorder's root cause. https://www.japantimes.co.jp/news/2025/09/09/japan/science-health/takeda-narcolepsy/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #takeda #health #pharmaceuticals #sleep